title: Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
authors.forename: K
authors.initials: K
authors.lastname: ten Freyhaus
authors.forename: B
authors.initials: B
authors.lastname: Homey
authors.forename: T
authors.initials: T
authors.lastname: Bieber
authors.forename: D
authors.initials: D
authors.lastname: Wilsmann-Theis
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D017511:Pyoderma Gangrenosum / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib